Metrics Contract Services

The 11,700m2 facility in Greenville, North Carolina specializes in complex dosage forms including potent compounds, Schedule II-V controlled substances, inherently unstable compounds and products with poor bioequivalence. The Greenville site:

• Offers quality pharmaceutical formulation development, analytical testing services and commercial and Phase I, II and III Clinical Trial Manufacturing (CTM).
• Offers particular expertise in First-Time-In-Man (FTIM) and Phase I, II, and III CTM - conducting more than 140 FTIM projects for different chemical entities while concurrently developing more than 700 CTM batches.
• Is GMP compliant as certified by chief regulatory authorities (FDA and MHRA).
• Includes an established manufacturing facility with capacity to produce over 1.0 billion tablets and capsules annually.
• Is capable of handling potent products and is DEA-approved for Schedule II-V controlled substances.